Dishman is building the biggest oncology and high potency drugs facility in Asia at its Bavla plant. The Rs500m ($11m) facility is being commissioned by Dishman's Carbogen Amcis subsidiary, which will also operate the facility. In addition, Dishman Pharmaceuticals is investing Rs5bn ($115m) in two special economic zones near Bavla. The chemicals and pharmaceutical zone is expected to house 50 facilities and the engineering zone 100 facilities. Work on the zones will start before the end of the year.
Business Standard
Financial Express
Sunday 31 August 2008
Dishman builds Carbogen Amcis facility
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment